| Basics |
Cellectis S.A.
Cellectis SA is a gene-editing company, employing its core proprietary technologies to develop products in the emerging field of immuno-oncology. Its two segment includes Therapeutics and Plants.
|
| IPO Date: |
March 25, 2015 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$475.54M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.36 | 2.54%
|
| Avg Daily Range (30 D): |
$0.10 | 2.50%
|
| Avg Daily Range (90 D): |
$0.11 | 2.97%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.19M |
| Avg Daily Volume (30 D): |
.09M |
| Avg Daily Volume (90 D): |
.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
131 |
| Avg Trade Size (Sh.) (30 D): |
132 |
| Avg Trade Size (Sh.) (90 D): |
144 |
| Institutional Trades |
| Total Inst.Trades: |
212 |
| Avg Inst. Trade: |
$1.71M |
| Avg Inst. Trade (30 D): |
$.99M |
| Avg Inst. Trade (90 D): |
$.99M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.75M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
78.35K |
|
|
|
|
|
